Table II.

KRAS and NRAS analysis of tissue samples.

RAS status	No. of patients (%)
Wild-type KRAS	6 (19.35)
Mutated KRAS	25 (80.65)
Exon 2 codon 12	19 (76.00)
G12A	4
G12C	3
G12D	10
G12V	2
Exon 2 codon 13	5 (20.00)
G13D	4
G13V	1
Exon 3 codon 59	0 (0.00)
Exon 3 codon 61	0 (0.00)
Exon 4 codon 117	0 (0.00)
Exon 4 codon 146	1 (4.00)
A146P	1
Wild-type NRAS	30 (96.77)
Mutated NRAS	1 (3.23)
Exon 2 codon 12	1 (100.00)
G12D	1
Exon 2 codon 13	0 (0.00)
Exon 3 codon 59	0 (0.00)
Exon 3 codon 61	0 (0.00)
Exon 4 codon 117	0 (0.00)
Exon 4 codon 146	0 (0.00)
Undefined	0 (0.00)